Levin Capital Strategies, L.P.
Source: SEC Form 13F · as of Mar 2026Levin Capital Strategies, L.P. holds 4 biotech & pharma companies tracked by BioSniper, totaling $6.6M in value as of Mar 2026 (SEC Form 13F).
Companies held
4
Total value held
$6.6M
BioSniper AIPage evidence connected
Prepared research question
What matters most for ARS Pharmaceuticals, Inc. (SPRY)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| SPRYARS Pharmaceuticals, Inc. | 552,561 | $4.4M |
| DRTSAlpha Tau Medical Ltd. | 106,423 | $752K |
| SMMTSummit Therapeutics Inc. | 37,676 | $714K |
| FLGTFulgent Genetics Inc. | 43,234 | $687K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.